Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRVI Trevi Therapeutics Inc.

交易中 01-06 11:13:02 EST

4.44

-0.15

-3.27%

最高4.68	最低4.36	成交量16.48万
今开4.64	昨收4.59	日振幅6.97%
总市值3.97亿	流通市值2.68亿	总股本8,937万
成交额73.23万	换手率0.27%	流通股本6,027万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRVI","market":"US","secType":"STK","nameCN":"Trevi Therapeutics Inc.","latestPrice":4.44,"timestamp":1736179977419,"preClose":4.59,"halted":0,"volume":164751,"delay":0,"floatShares":60269900,"shares":89365700,"eps":-0.443732,"marketStatus":"交易中","change":-0.15,"latestTime":"01-06 11:13:02 EST","open":4.64,"high":4.68,"low":4.36,"amount":732349.8766173001,"amplitude":0.069717,"askPrice":4.45,"askSize":439,"bidPrice":4.43,"bidSize":42,"shortable":3,"etf":0,"ttmEps":-0.443732,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1736197200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1557201600000,"exchange":"NASDAQ","adjPreClose":4.59,"preHourTrading":{"tag":"盘前","latestPrice":4.6108,"preClose":4.59,"latestTime":"09:29 EST","volume":2636,"amount":12157.2760212,"timestamp":1736173781479},"postHourTrading":{"tag":"盘后","latestPrice":4.52,"preClose":4.59,"latestTime":"19:59 EST","volume":7047,"amount":32308.9595,"timestamp":1735952398321},"volumeRatio":0.858153,"impliedVol":1.201,"impliedVolPercentile":0.6653},"requestUrl":"/m/hq/s/TRVI/tweets","defaultTab":"tweets","newsList":[{"id":"2500286221","title":"Trevi Therapeutics, Inc.盘中异动 下午盘急速拉升5.05%报4.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500286221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500286221?lang=zh_cn&edition=full","pubTime":"2025-01-04 03:04","pubTimestamp":1735931072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日03时04分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010403043395f7f9d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010403043395f7f9d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","TRVI"],"gpt_icon":0},{"id":"2500909975","title":"Trevi Therapeutics, Inc.盘中异动 早盘快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500909975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500909975?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:34","pubTimestamp":1735832046,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时34分，Trevi Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102233406a213117b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102233406a213117b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","TRVI"],"gpt_icon":0},{"id":"2495525202","title":"Trevi Therapeutics, Inc.盘中异动 快速跳水5.50%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495525202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495525202?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:38","pubTimestamp":1735569522,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时38分，Trevi Therapeutics, Inc.股票出现波动，股价急速跳水5.50%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223842a20f2d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223842a20f2d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2494898213","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨5.34%报4.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494898213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494898213?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:55","pubTimestamp":1735311350,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时55分，Trevi Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。截至发稿，该股报4.44美元/股，成交量2.6101万股，换手率0.03%，振幅4.51%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227225551a20c0384&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227225551a20c0384&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","LENZ","BK4139"],"gpt_icon":0},{"id":"2494896508","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.00%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494896508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494896508?lang=zh_cn&edition=full","pubTime":"2024-12-27 02:28","pubTimestamp":1735237718,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日02时28分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报4.20美元/股，成交量29.2205万股，换手率0.33%，振幅4.27%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227022838ab93bd38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227022838ab93bd38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","TRVI"],"gpt_icon":0},{"id":"2493472279","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472279?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:08","pubTimestamp":1734714520,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时08分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221010840a1fe69fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221010840a1fe69fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","TRVI","LENZ"],"gpt_icon":0},{"id":"2492356174","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492356174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492356174?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:32","pubTimestamp":1734618737,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时32分，Trevi Therapeutics, Inc.股票出现波动，股价急速拉升6.02%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.76%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922322795ea7a92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922322795ea7a92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","TRVI"],"gpt_icon":0},{"id":"2492998539","title":"Trevi Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.19%报4.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492998539?lang=zh_cn&edition=full","pubTime":"2024-12-18 00:54","pubTimestamp":1734454460,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日00时54分，Trevi Therapeutics, Inc.股票出现异动，股价快速上涨5.19%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121800542195ea349b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121800542195ea349b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2491180976","title":"Trevi Therapeutics, Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491180976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491180976?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:25","pubTimestamp":1734362723,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时25分，Trevi Therapeutics, Inc.股票出现异动，股价大幅拉升5.03%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216232523984c729d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216232523984c729d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2490386483","title":"BUZZ--美国股票走势-Riot Platforms、Archer、J.Jill","url":"https://stock-news.laohu8.com/highlight/detail?id=2490386483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490386483?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:42","pubTimestamp":1734018141,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.09%，报44,110.17点；标普500指数.SPX下跌0.18%，报6,073.42点；纳斯达克综合指数.IXIC下跌0.28%，报19,979.74点。标准普尔 500 指数.PG.INX涨幅前三名是： ** 华纳兄弟发现公司WBD.OQ，上涨 12.7. ** 大都会人寿MET.N，上涨 4.7 标准普尔 500 指数.PL.INX跌幅前三名： ** Adobe Inc ADBE.OQ，下跌 12.5. nL4N3ND0YY  ** 华纳兄弟发现公司WBD.O:BUZZ - 因计划分拆电视和流媒体部门而上涨 nL4N3ND10C  ** Middleby Corp MIDD.O:BUZZ - 因Jefferies将其评级下调至 \"持有\"，并下调预期收益率而下滑。nL4N3ND10Q  ** MMTec Inc MTC.O:BUZZ - 在宣布反向股票分割后下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4S3ND17P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUK","BURL","BK4187","MET","CHWY","CIEN","MDLZ","ALGT","TPL","TRVI","KROS","KGS","CNC","BPT","CNP","ORA","KR","MIDD","CMS","BN","MTC","DTE","WBD","TMUS","ACI","LOVE","CZR","SPGC","CMCSA","ROK","SRFM","ABT","BEPC","JILL","OXM","BNED","MMC","ACHR","FISI","SFHG","GD","TSYW.SI","RIOT","ADBE","PALI","DDD","NDSN"],"gpt_icon":1},{"id":"2490384506","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨56.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490384506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490384506?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:31","pubTimestamp":1734013868,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时31分，Trevi Therapeutics, Inc.股票出现异动，股价大幅上涨56.67%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1818.10%、398.68%、48.84%，振幅较大的相关个股有Os Therapies Incorporated、Entero Therapeutics Inc.、Enlivex Therapeutics Ltd.，振幅分别为10.63%、8.37%、5.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223108ab72a7cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223108ab72a7cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","TRVI"],"gpt_icon":0},{"id":"2490861324","title":"Trevi Therapeutics, Inc.盘中异动 快速跳水5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490861324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490861324?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:47","pubTimestamp":1733932063,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时47分，Trevi Therapeutics, Inc.股票出现波动，股价急速跳水5.60%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234744a1e691c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234744a1e691c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","LENZ","BK4139"],"gpt_icon":0},{"id":"2490702913","title":"Trevi Therapeutics, Inc.盘中异动 急速下跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490702913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490702913?lang=zh_cn&edition=full","pubTime":"2024-12-10 03:44","pubTimestamp":1733773497,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日03时44分，Trevi Therapeutics, Inc.股票出现波动，股价快速下跌5.80%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210034458ab6a9ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210034458ab6a9ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2489025315","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.77%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489025315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489025315?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:38","pubTimestamp":1733503107,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时38分，Trevi Therapeutics, Inc.股票出现波动，股价大幅上涨5.77%。截至发稿，该股报2.75美元/股，成交量8.81万股，换手率0.11%，振幅5.77%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120700382798e5e71a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120700382798e5e71a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","TRVI"],"gpt_icon":0},{"id":"2488194205","title":"Trevi Therapeutics, Inc.盘中异动 早盘快速下挫6.29%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488194205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488194205?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:31","pubTimestamp":1733322665,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时31分，Trevi Therapeutics, Inc.股票出现波动，股价大幅跳水6.29%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223105a26c5d34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223105a26c5d34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","BK4139","LENZ"],"gpt_icon":0},{"id":"2485169032","title":"Trevi Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485169032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485169032?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:07","pubTimestamp":1732306026,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时07分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升5.08%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123040706abd8179a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123040706abd8179a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2484145334","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484145334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484145334?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:26","pubTimestamp":1732116399,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时26分，Trevi Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120232639a248dd44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120232639a248dd44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","TRVI"],"gpt_icon":0},{"id":"2484197804","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484197804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484197804?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:24","pubTimestamp":1732037051,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时24分，Trevi Therapeutics, Inc.股票出现波动，股价急速拉升5.14%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001241298e438fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001241298e438fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","BK4139","LENZ"],"gpt_icon":0},{"id":"2483938102","title":"Trevi Therapeutics, Inc.盘中异动 临近午盘股价大涨5.07%报3.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483938102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483938102?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:00","pubTimestamp":1731603624,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时00分，Trevi Therapeutics, Inc.股票出现波动，股价大幅上涨5.07%。截至发稿，该股报3.01美元/股，成交量58.8114万股，换手率0.77%，振幅6.29%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501002498e42b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501002498e42b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","TRVI"],"gpt_icon":0},{"id":"2483538564","title":"Trevi Therapeutics, Inc.2024财年第三财季实现净利润-13.24百万美元，同比减少71.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483538564?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600031,"startTime":"0","endTime":"0","summary":"11月15日，Trevi Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-13.24百万美元，同比减少71.95%；其中营业收入为0.00美元，每股基本收益为-0.13美元。从资产负债表来看，Trevi Therapeutics, Inc.总负债9.94百万美元，其中短期债务297000.00美元，资产负债比为6.94，流动比率为7.39。机构评级：截至2024年11月15日，当前有10家机构对Trevi Therapeutics, Inc.目标价做出预测，其中目标均价为8.90美元，其中最低目标价为6.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000042a237ff7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000042a237ff7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TRVI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trevitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0749},{"period":"1month","weight":0.7654},{"period":"3month","weight":0.5199},{"period":"6month","weight":0.7791},{"period":"1year","weight":2.3261},{"period":"ytd","weight":0.1141}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Trevi Therapeutics, Inc.于2011年3月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化纳布啡ER，以治疗严重的神经介导的疾病。该公司目前正在开发纳布啡ER，用于治疗患有特发性肺纤维化或IPF的慢性瘙痒，慢性咳嗽，以及帕金森病患者的左旋多巴诱导的运动障碍或LID。这些病症具有共同的病理生理学，其通过中枢和外周神经系统中的阿片受体介导。由于纳布啡作为阿片受体调节剂的作用机制，该公司认为这有可能有效治疗这些疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.125951},{"month":2,"riseRate":0.8,"avgChangeRate":0.214835},{"month":3,"riseRate":0.4,"avgChangeRate":0.397594},{"month":4,"riseRate":0.4,"avgChangeRate":0.130673},{"month":5,"riseRate":0,"avgChangeRate":-0.142766},{"month":6,"riseRate":0.833333,"avgChangeRate":0.27262},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.074501},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.08811},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.120284},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.120364},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.07561},{"month":12,"riseRate":0.666667,"avgChangeRate":0.048916}],"exchange":"NASDAQ","name":"Trevi Therapeutics Inc.","nameEN":"Trevi Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Trevi Therapeutics Inc.,TRVI,Trevi Therapeutics Inc.股票,Trevi Therapeutics Inc.股票老虎,Trevi Therapeutics Inc.股票老虎国际,Trevi Therapeutics Inc.行情,Trevi Therapeutics Inc.股票行情,Trevi Therapeutics Inc.股价,Trevi Therapeutics Inc.股市,Trevi Therapeutics Inc.股票价格,Trevi Therapeutics Inc.股票交易,Trevi Therapeutics Inc.股票购买,Trevi Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}